US launches trade investigation into Germany over drug pricing
• U.S. Trade Representative Jamieson Greer announced on Thursday that the U.S. has launched a trade investigation into Germany's pharmaceutical pricing policies. • The probe follows an April proposal by the German Ministry of Health to overhaul its statutory healthcare system to close a 20 billion euro ($23 billion) funding gap. • Washington is investigating whether Germany's plan to lower spending on drug products is unreasonable or discriminatory toward U.S. companies.
reuters.com
